IL1B and COVID-19: Serum IL-1β was measured in 46 COVID-19 patients in intensive care (median 0.35 pg./mL), in 30 COVID-19 patients not in intensive care (median 0.32 pg./mL), and in 24 healthy volunteers (median IL-1β 0.11 pg./mL).